![](https://endpts.com/wp-content/uploads/2020/10/News_briefing_FE.jpg)
Rona Therapeutics raises $35M; Actuate now plans for $22M IPO
Shanghai-based RNA company raises $35 million: Rona Therapeutics’ Series A+ round was led by LongRiver Investments. Investors include Lilly Asia Ventures …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.